At APH, we offer a range of regenerative therapies designed to support the body’s innate healing processes and promote overall wellness. These therapies are intended to complement conventional care by addressing systemic imbalances, reducing inflammatory burden, and enhancing cellular function. Patient care for these therapies is led by our Medical Director Bonnie Friehling, MD, with treatment administered by our dedicated nursing team.
Extracorporeal Blood Oxygenation & Ozonation (EBOO)
EBOO is an integrative therapy in which a portion of a patient’s blood is circulated through a sterile extracorporeal system and exposed to controlled oxygenation, ozonation, and, when indicated, ultraviolet blood irradiation. The processed blood is then returned to the body with the aim of supporting immune regulation, oxidative balance, and cellular health. EBOO protocols, including session duration and frequency, are tailored to each individual following clinical evaluation by our medical team. Read More about EBOO.
IV (Intravenous) Therapies
IV therapies deliver targeted nutrients, antioxidants, and hydration directly into the bloodstream to support metabolic function, cellular recovery, and overall physiological resilience. These therapies may include vitamin and mineral infusions, antioxidant support (such as glutathione), hydration formulas, and custom blends designed for specific health goals. IV therapy can be used to support recovery from fatigue, immune challenges, chronic stress, nutrient depletion, and other conditions identified during patient consultation.
Our IV therapy options include foundational nutrient infusions, high-dose vitamin C therapy, peptide-based IV support, calming and nervous system–focused infusions, methylene blue IV paired with red or infrared light therapy, NAD+ therapy for cellular and metabolic support, and EDTA chelation therapy for detoxification and vascular support. Optional IV and injectable add-ons may include magnesium, glutathione, procaine, anti-inflammatory support, lipotropic injections, and select peptide therapies, based on clinical evaluation and provider recommendation.
